The regulation of immunity through the control of TE expression is an emerging research field in cancer, and SETDB1 has been in the spotlight as the key regulator for suppressing innate immunity by limiting the overall abundance of TE transcripts in cancer cells (Guler et al., 2017). Here, SETDB1 is linked to cancer.